1. Home
  2. GKOS vs SLM Comparison

GKOS vs SLM Comparison

Compare GKOS & SLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • SLM
  • Stock Information
  • Founded
  • GKOS 1998
  • SLM 1972
  • Country
  • GKOS United States
  • SLM United States
  • Employees
  • GKOS N/A
  • SLM N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • SLM Finance: Consumer Services
  • Sector
  • GKOS Health Care
  • SLM Finance
  • Exchange
  • GKOS Nasdaq
  • SLM Nasdaq
  • Market Cap
  • GKOS 5.1B
  • SLM 5.9B
  • IPO Year
  • GKOS 2015
  • SLM N/A
  • Fundamental
  • Price
  • GKOS $89.91
  • SLM $32.18
  • Analyst Decision
  • GKOS Strong Buy
  • SLM Buy
  • Analyst Count
  • GKOS 13
  • SLM 11
  • Target Price
  • GKOS $135.15
  • SLM $30.45
  • AVG Volume (30 Days)
  • GKOS 1.1M
  • SLM 2.4M
  • Earning Date
  • GKOS 04-30-2025
  • SLM 04-24-2025
  • Dividend Yield
  • GKOS N/A
  • SLM 1.63%
  • EPS Growth
  • GKOS N/A
  • SLM N/A
  • EPS
  • GKOS N/A
  • SLM 2.78
  • Revenue
  • GKOS $404,523,000.00
  • SLM $1,449,130,000.00
  • Revenue This Year
  • GKOS $27.84
  • SLM $12.94
  • Revenue Next Year
  • GKOS $27.88
  • SLM $9.65
  • P/E Ratio
  • GKOS N/A
  • SLM $11.48
  • Revenue Growth
  • GKOS 23.92
  • SLM N/A
  • 52 Week Low
  • GKOS $77.10
  • SLM $19.39
  • 52 Week High
  • GKOS $163.71
  • SLM $32.65
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.80
  • SLM 69.37
  • Support Level
  • GKOS $84.26
  • SLM $27.95
  • Resistance Level
  • GKOS $92.27
  • SLM $32.46
  • Average True Range (ATR)
  • GKOS 3.94
  • SLM 0.94
  • MACD
  • GKOS 0.57
  • SLM 0.52
  • Stochastic Oscillator
  • GKOS 58.87
  • SLM 95.60

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About SLM SLM Corporation

SLM Corp is the largest student lender in the country. It makes and holds student loans through the guaranteed Federal Family Education Loan Program as well as through private channels. It also engages in debt-management operations, including accounts receivable and collections services, and runs college savings programs.

Share on Social Networks: